BERKELEY, Calif., and VANCOUVER, British Columbia, March 25, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...
BERKELEY, Calif., and VANCOUVER, British Columbia, March 20, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...
BERKELEY, Calif., and VANCOUVER, British Columbia, March 18, 2019 – BriaCell® Therapeutics Corp. (“BriaCell®” or ...
BERKELEY, Calif., and VANCOUVER, British Columbia, February 26, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...
· New insights into BriaDX™, BriaCell’s simple patient HLA-type identification test, will be presented at ...
BERKELEY, Calif., and VANCOUVER, British Columbia, February 12, 2019 – BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) ...
· Completed development of a novel frozen formulation of Bria-IMT™ for on-demand shipment to clinical ...
· Interim data indicate an excellent safety profile for the combination regimen in advanced breast ...
Note: This Press Release contains amendments to the press release previously issued on Nov. 19, ...
· Positive proof of concept data with Bria-IMT™ Monotherapy will highlight potent anti-tumor activity and ...